Craig-Hallum analyst Per Ostlund raised his price target for Exact Sciences to $115 from $95 saying that while Q1 is typically thought of as a seasonally challenged quarter sequentially, the company blew past Cologuard volume guidance and raised its 2019 outlook. The analyst reiterates a Buy rating on the shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.